Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gemini Therapeutics, Inc.

1.35
0.0000
Volume:- -
Turnover:85.98K
Market Cap:5.85M
PE:-0.13
High:1.35
Open:1.35
Low:1.35
Close:1.35
Loading ...
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 01, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 01, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 31, 2022

Major Issues Report

8-K - Current report
Oct 31, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 27, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 11, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 12, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals